Table 1 Patient characteristics
Total patients | (n = 36) |
|---|---|
Age, median (IQR), years | 63 (10) |
Tumor classification | |
cT1 | 27 (75.0%) |
cT2 | 9 (25.0%) |
Gleason Score | |
3-5 | 8 (22.2%) |
6 | 23 (63.9%) |
7 | 5 (13.9%) |
Pre-treatment PSA | |
≤10 ng/mL | 31 (86.1%) |
>10 ng/mL | 5 (13.9%) |
Percent positive biopsies | |
≤ 50% | 17 (47.2%) |
> 50% | 14 (38.9%) |
Unknown | 5 (13.9%) |
Risk group | |
Low | 28 (77.8%) |
Intermediate | 8 (22.2%) |